SEC
MYOK

Seven Eight Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Seven Eight Capital’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,200
Closed -$223K – 619
2017
Q3 		$223K Buy
+5,200
New +$166K 0.03% 411

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Seven Eight Capital's MYOK Position: Q4 2017 in Review

Seven Eight Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 5,200 shares — an estimated $223K sold.

Seven Eight Capital first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $223K in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • Seven Eight Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Seven Eight Capital sold 5,200 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $223K.
  • Seven Eight Capital first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Seven Eight Capital's MyoKardia, Inc. Common Stock position peaked at $223K in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Seven Eight Capital's 13F filing for Q4 2017, filed 12 Feb 2018.